Universal Ibogaine Inc. Stock Toronto S.E.
Equities
IBO
CA69379R1082
Healthcare Facilities & Services
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.01 CAD | -33.33% | -33.33% | +100.00% |
06-06 | Universal Ibogaine Inc. cancelled the transaction announced on April 22, 2024 | CI |
06-06 | Universal Ibogaine Inc. announced that it has received CAD 0.27 million in funding | CI |
Sales 2022 | 1.07 1.47 | Sales 2023 | 1.03 1.42 | Capitalization | 2.87M 3.95M |
---|---|---|---|---|---|
Net income 2022 | -10M -13.76M | Net income 2023 | -2M -2.75M | EV / Sales 2022 | 8,069,982 x |
Net Debt 2022 | 1.01M 1.39M | Net Debt 2023 | 2.46M 3.39M | EV / Sales 2023 | 5,181,017 x |
P/E ratio 2022 |
-0.67
x | P/E ratio 2023 |
-1.2
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99% |
1 day | -33.33% |
Managers | Title | Age | Since |
---|---|---|---|
Nicholas Karos
CEO | Chief Executive Officer | - | 22-01-09 |
Greg J. Leavens
DFI | Director of Finance/CFO | 59 | - |
Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Nicholas Karos
CEO | Chief Executive Officer | - | 22-01-09 |
James Duncan
BRD | Director/Board Member | - | 23-09-30 |
1st Jan change | Capi. | |
---|---|---|
+24.66% | 88.38B | |
-21.76% | 77.56B | |
+1.76% | 26.97B | |
-13.50% | 16.57B | |
+3.23% | 15.81B | |
+77.51% | 13.65B | |
+76.96% | 13.06B | |
+4.72% | 12.61B | |
+36.67% | 12.56B |
- Stock Market
- Equities
- IBO Stock
- IBO Stock